{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:50:39Z","timestamp":1789523439095,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4t Hildesheim"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of this study was to analyze data of children and adolescents in Germany insured according to legal requirements (statutorily insured) regarding epidemiology, comorbidities, and care of bulimia nervosa (BN) pre- vs. intra-COVID-19 pandemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study is based on anonymized claims data of 10\u201317.9\u00a0years old children and adolescents statutorily insured in Germany from the InGef\u00a0Berlin GmbH research database. The database combines data of more than 50 statutory health insurances and is representative of the German population. Prevalence, (quarterly) incidence, comorbidities and in- and outpatient treatment of BN (ICD-10: F50.2\/F50.3) pre-COVID (01\/2018-03\/2020; N\u2009=\u2009282,711) vs. intra-COVID (04\/2020-12\/2021; N\u2009=\u2009282,738) was compared using descriptives and \u03c7<jats:sup>2<\/jats:sup> tests, Welch-tests and interrupted time series analysis. The analysis was stratified by age groups (children: 10\u201313\u00a0years; adolescents: 14\u201317\u00a0years).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Prevalence of BN was 0.09% pre-COVID and 0.07% intra-COVID (OR\u2009=\u20090.78 [0.65, 0.93]). After pandemic onset, a positive trend in the quarterly incidence among adolescents was observed (<jats:italic>p<\/jats:italic>\u2009=\u2009.016). Outpatient visits to general practitioners decreased (OR\u2009=\u20090.59 [0.35, 0.98]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The observed decline in diagnosed and treated BN cases and the positive trend in quarterly incidence could be attributed to an increase in unregistered cases due to the overburdened care situation that emerged with the onset of the COVID-19 pandemic. Researchers and healthcare providers need to be aware of the potential for a backlash and deterioration\/chronification of BN symptoms in children and adolescents.<\/jats:p>\n            <jats:p>\n              <jats:italic>Level of evidence<\/jats:italic> No level of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40519-025-01738-z","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T21:08:45Z","timestamp":1742677725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreasing prevalence or increase in unregistered cases of bulimia nervosa in children and adolescents in Germany? A comparison using representative claims data pre- vs. intra-COVID-19 pandemic"],"prefix":"10.1007","volume":"30","author":[{"given":"Jule","family":"Leickert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zillmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Vivirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Pintsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"1738_CR1","unstructured":"Besprechung der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der L\u00e4nder vom 22.03.2020: Erweiterung der beschlossenen Leitlinien zur Beschr\u00e4nkung sozialer Kontakte. Bundesregierung. 2020.\u00a0https:\/\/www.bundesregierung.de\/breg-de\/service\/archiv\/besprechung-der-bundeskanzlerin-mit-den-regierungschefinnen-und-regierungschefs-der-laender-vom-22-03-2020-1733248. Accessed 11 Jul 2024."},{"issue":"7","key":"1738_CR2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00112-023-01775-x","volume":"171","author":"U Ravens-Sieberer","year":"2023","unstructured":"Ravens-Sieberer U, Kaman A, Devine J, Rei\u00df F (2023) The COVID-19 pandemic\u2014How did it affect the mental health of children? Monatsschrift Kinderheilkunde 171(7):608\u2013614","journal-title":"Monatsschrift Kinderheilkunde"},{"issue":"1","key":"1738_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/eat.23704","volume":"56","author":"DJ Devoe","year":"2022","unstructured":"Devoe DJ, Han A, Anderson A, Katzman DK, Patten SB, Soumbasis A (2022) The impact of the COVID-19 pandemic on eating disorders: a systematic review. Int J Eat Disord 56(1):5\u201325","journal-title":"Int J Eat Disord"},{"key":"1738_CR4","unstructured":"DAK. Kinder- und Jugendreport 2023: Gesundheit und Gesundheitsversorgung w\u00e4hrend und nach der Pandemie. https:\/\/caas.content.dak.de\/caas\/v1\/media\/45534\/data\/b14be3b0db47242833904ba75c5239cb\/dak-kinder-und-jugendreport-2023-report.pdf. Accessed 11 Dec 2023."},{"issue":"11","key":"1738_CR5","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/eat.23368","volume":"53","author":"G Castellini","year":"2020","unstructured":"Castellini G, Cassioli E, Rossi E, Innocenti M, Gironi V, Sanfilippo G, Felciai F, Monteleone AM, Ricca V (2020) The impact of COVID-19 epidemic on eating disorders: a longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls. Int J Eat Disord 53(11):1855\u20131862. https:\/\/doi.org\/10.1002\/eat.23368","journal-title":"Int J Eat Disord"},{"issue":"1","key":"1738_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40519-023-01547-2","volume":"28","author":"\u00c2 G\u00fczel","year":"2023","unstructured":"G\u00fczel \u00c2, Mutlu NL, Molendijk M (2023) COVID-19-related changes in eating disorder pathology, emotional and binge eating and need for care: a systematic review with frequentist and Bayesian meta-analyses. Eat Weight Disord 28(1):19. https:\/\/doi.org\/10.1007\/s40519-023-01547-2","journal-title":"Eat Weight Disord"},{"key":"1738_CR7","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2022.2345","author":"B Herpertz-Dahlmann","year":"2022","unstructured":"Herpertz-Dahlmann B, Dempfle A, Eckardt S (2022) The youngest are hit hardest: The influence of the COVID-19 pandemic on the hospitalization rate for children, adolescents, and young adults with anorexia nervosa in a large German representative sample. Eur Psychiatry. https:\/\/doi.org\/10.1192\/j.eurpsy.2022.2345","journal-title":"Eur Psychiatry"},{"issue":"8","key":"1738_CR8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/jcpp.13800","volume":"64","author":"N Auger","year":"2023","unstructured":"Auger N, Steiger H, Luu TM, Chadi N, Low N, Bilodeau-Bertrand M et al (2023) Shifting age of child eating disorder hospitalizations during the Covid-19 pandemic. J Child Psychol Psychiatry 64(8):1176\u20131184","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"1738_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1024\/1422-4917\/a000935","volume":"51","author":"MG K\u00f6lch","year":"2023","unstructured":"K\u00f6lch MG, Reis O, Ulbrich L, Schepker R (2023) COVID-19 und psychische St\u00f6rungen bei Minderj\u00e4hrigen: Ver\u00e4nderungen der Behandlungen nach der Krankenhausstatistik. Z Kinder Jugendpsychiatr Psychother 51(4):295\u2013309","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"key":"1738_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.puhe.2022.02.013","volume":"206","author":"M Ludwig","year":"2022","unstructured":"Ludwig M, Enders D, Basedow F, Walker J, Jacob J (2022) Sampling strategy, characteristics and representativeness of the InGef research database. Public Health Mai 206:57\u201362","journal-title":"Public Health Mai"},{"key":"1738_CR11","first-page":"1","volume":"22","author":"M Bl\u00fcmel","year":"2020","unstructured":"Bl\u00fcmel M, Spranger A, Achstetter K, Maresso A, Busse R (2020) Germany: health system review. Health Syst Transit 22:1\u2013272","journal-title":"Health Syst Transit"},{"issue":"10097","key":"1738_CR12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(17)31280-1","volume":"390","author":"R Busse","year":"2017","unstructured":"Busse R, Bl\u00fcmel M, Knieps F, B\u00e4rnighausen T (2017) Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet 390(10097):882\u2013897","journal-title":"Lancet"},{"key":"1738_CR13","volume-title":"Internationale Klassifikation Psychischer St\u00f6rungen (10. Aufl., unter Ber\u00fccksichtigung der \u00c4nderungen entsprechend ICD-10-GM 2015)","author":"H Dilling","year":"2015","unstructured":"Dilling H, Mombour W, Schmidt MH (2015) Internationale Klassifikation Psychischer St\u00f6rungen (10. Aufl., unter Ber\u00fccksichtigung der \u00c4nderungen entsprechend ICD-10-GM 2015). Hogrefe, G\u00f6ttingen"},{"key":"1738_CR14","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Taylor & Francis Group, Florence"},{"key":"1738_CR15","unstructured":"Bundeskanzlerin, Regierungschefinnen und Regierungschefs der L\u00e4nder. Videoschaltkonferenz der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der L\u00e4nder am 10. 2021. Accessed 8 Aug 2024."},{"issue":"6","key":"1738_CR16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/erv.2773","volume":"28","author":"S Schlegl","year":"2020","unstructured":"Schlegl S, Meule A, Favreau M, Voderholzer U (2020) Bulimia nervosa in times of the COVID-19 pandemic-Results from an online survey of former inpatients. Eur Eat Disord Rev 28(6):847\u2013854","journal-title":"Eur Eat Disord Rev"},{"issue":"1","key":"1738_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/nu14010100","volume":"14","author":"I Baenas","year":"2021","unstructured":"Baenas I, Etxandi M, Mungu\u00eda L, Granero R, Mestre-Bach G, S\u00e1nchez I et al (2021) Impact of COVID-19 lockdown in eating disorders: a multicentre collaborative international study. Nutrients 14(1):100","journal-title":"Nutrients"},{"issue":"11","key":"1738_CR18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/eat.23374","volume":"53","author":"S Schlegl","year":"2020","unstructured":"Schlegl S, Maier J, Meule A, Voderholzer U (2020) Eating disorders in times of the COVID-19 pandemic\u2014Results from an online survey of patients with anorexia nervosa. Int J Eat Disord 53(11):1791\u20131800","journal-title":"Int J Eat Disord"},{"key":"1738_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-023-00843-","author":"AC Schlissel","year":"2023","unstructured":"Schlissel AC, Richmond TK, Eliasziw M, Leonberg K, Skeer MR (2023) Anorexia nervosa and the COVID-19 pandemic among young people: a scoping review. J Eat Disord. https:\/\/doi.org\/10.1186\/s40337-023-00843-","journal-title":"J Eat Disord"},{"key":"1738_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-021-00419-3","author":"W Spettigue","year":"2021","unstructured":"Spettigue W, Obeid N, Erbach M, Feder S, Finner N, Harrison ME (2021) The impact of COVID-19 on adolescents with eating disorders: a cohort study. J Eat Disord. https:\/\/doi.org\/10.1186\/s40337-021-00419-3","journal-title":"J Eat Disord"},{"issue":"1","key":"1738_CR21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.21182","volume":"23","author":"M Solmi","year":"2024","unstructured":"Solmi M, Monaco F, H\u00f8jlund M, Monteleone AM, Trott M, Firth J (2024) Outcomes in people with eating disorders: a transdiagnostic and disorder-specific systematic review, meta-analysis and multivariable meta-regression analysis. World Psychiatry 23(1):124\u2013138","journal-title":"World Psychiatry"},{"issue":"4","key":"1738_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00103-013-1916-x","volume":"57","author":"F Hoffmann","year":"2014","unstructured":"Hoffmann F, Bachmann CJ (2014) Unterschiede in den soziodemografischen Merkmalen, der Gesundheit und Inanspruchnahme bei Kindern und Jugendlichen nach ihrer Krankenkassenzugeh\u00f6rigkeit. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(4):455\u2013463","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1738_CR23","first-page":"1","volume-title":"S3-Leitlinie Diagnostik und Behandlung der Essst\u00f6rungen","author":"MM Fichter","year":"2019","unstructured":"Fichter MM (2019) Epidemiologie der Ess- und F\u00fctterst\u00f6rungen. In: Herpertz S, Fichter M, Herpertz-Dahlmann B, Hilbert A, Tuschen-Caffier B, Vocks S, Zeeck A (eds) S3-Leitlinie Diagnostik und Behandlung der Essst\u00f6rungen. Springer, Berlin, Heidelberg, pp 1\u201318"},{"issue":"6","key":"1738_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/YCO.0000000000000278","volume":"29","author":"A Keski-Rahkonen","year":"2016","unstructured":"Keski-Rahkonen A, Mustelin L (2016) Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry 29(6):340\u2013345. https:\/\/doi.org\/10.1097\/YCO.0000000000000278","journal-title":"Curr Opin Psychiatry"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-025-01738-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40519-025-01738-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-025-01738-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T21:09:13Z","timestamp":1742677753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40519-025-01738-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1007\/s40519-025-01738-z","relation":{},"ISSN":["1590-1262"],"issn-type":[{"value":"1590-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to anonymization of the claims data within the InGef Berlin GmbH\u00a0database (secondary data) ethics approval for this study was not required. No individuals, statutory health insurance companies or health care service providers can be identified. InGef provided the anonymised secondary data required for the project and has the necessary authorisations to use the data from the participating health insurance and the competent authorities. The study was conducted according to the following national and international guidelines: Good Practice of Secondary Data Analysis, Good epidemiological practice, Guidelines for Good Pharmacoepidemiology Practice, ENCePP-Guidelines for Methodological Standards in Pharmacoepidemiology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C.U. Correll has served as consultant\/advisor or received honoraria from: AbbVie, Alkermes, Allergan, Angelini, Aristo, Boehringer-Ingelheim, Bristol-Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Eli Lilly, Eumentis Therapeutics, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, MedInCell, MedLink, Merck, Mindpax, Mitsubishi Tanabe Pharma, Maplight, Mylan, Neumora Therapeutics, Neuraxpharm, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Saladax, Sanofi, Seqirus, Servier, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Terran, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen, Lundbeck and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, IntraCellular Therapies, Relmada, Reviva, Rovi. He has received grant support from Boehringer-Ingelheim, Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Medlink, Mindpax, Quantic, Terran.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}